These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33341181)

  • 1. Trajectories of Retention in Opioid Agonist Therapy and Overdose Risk During a Community-Wide Overdose Epidemic in a Canadian Setting.
    Socías ME; Dong H; Wood E; Nolan S; Hayashi K; Kerr T; Milloy MJ
    Am J Prev Med; 2021 Jan; 60(1):57-63. PubMed ID: 33341181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of retention in opioid agonist therapy in a Canadian setting.
    Socías ME; Dong H; Wood E; Brar R; Richardson L; Hayashi K; Kerr T; Milloy MJ
    Int J Drug Policy; 2020 Mar; 77():102696. PubMed ID: 32050143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N; DeBeck K; Milloy MJ; Nosova E; Fairbairn N; Wood E; Hayashi K
    Drug Alcohol Depend; 2018 Dec; 193():42-47. PubMed ID: 30340144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Fairbairn N; Milloy MJ; DeBeck K; Wood E; Kerr T
    Addict Behav; 2021 Jan; 112():106655. PubMed ID: 32977270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.
    McLeod KE; Buxton JA; Karim ME; Martin RE; Nosyk B; Kurz M; Scow M; Felicella G; Slaunwhite AK
    PLoS One; 2024; 19(7):e0306075. PubMed ID: 38985687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
    Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K
    Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.
    Palis H; Gan W; Xavier C; Desai R; Scow M; Sedgemore KO; Greiner L; Nicholls T; Slaunwhite A
    JAMA Netw Open; 2022 Nov; 5(11):e2243653. PubMed ID: 36416821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment.
    Bryson WC; Morasco BJ; Cotton BP; Thielke SM
    Subst Use Misuse; 2021; 56(5):697-703. PubMed ID: 33749499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: Findings from the OATS retrospective linkage study.
    Jones NR; Hickman M; Nielsen S; Larney S; Dobbins T; Ali R; Degenhardt L
    Drug Alcohol Depend; 2022 Jul; 236():109464. PubMed ID: 35523111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal methamphetamine use subgroups and associated addiction care access and overdose risk in a Canadian urban setting.
    Brooks O; Bach P; Dong H; Milloy MJ; Fairbairn N; Kerr T; Hayashi K
    Drug Alcohol Depend; 2022 Mar; 232():109274. PubMed ID: 35033951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Categorization of Opioid Use Among Pregnant People and Association With Overdose or Death.
    Camden A; To T; Ray JG; Gomes T; Bai L; Guttmann A
    JAMA Netw Open; 2022 May; 5(5):e2214688. PubMed ID: 35622361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
    Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis.
    Socías ME; Choi J; Lake S; Wood E; Valleriani J; Hayashi K; Kerr T; Milloy MJ
    Drug Alcohol Depend; 2021 Feb; 219():108420. PubMed ID: 33342591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denial of prescription pain medication among people who use drugs in Vancouver, Canada.
    Piret EM; Milloy MJ; Voon P; Choi J; DeBeck K; Hayashi K; Kerr T
    Harm Reduct J; 2024 Mar; 21(1):72. PubMed ID: 38549113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study.
    Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K
    Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum.
    J Addict Med; 2024 Mar-Apr 01; 18(2):e8. PubMed ID: 38478360
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting.
    Mackay L; Kerr T; Fairbairn N; Grant C; Milloy MJ; Hayashi K
    Addict Sci Clin Pract; 2021 Apr; 16(1):26. PubMed ID: 33910630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Extended-release Injectable Medications Help Curb United States and Canada's Opioid Overdose Epidemic?
    Socías ME; Nolan S
    J Addict Med; 2021 Jan-Feb 01; 15(1):15-17. PubMed ID: 32604134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada.
    Moallef S; Genberg BL; Hayashi K; Mehta SH; Kirk GD; Choi J; DeBeck K; Kipke M; Moore RD; Baum MK; Shoptaw S; Gorbach PM; Mustanski B; Javanbakht M; Siminski S; Milloy MJ
    Drug Alcohol Depend; 2022 Dec; 241():109633. PubMed ID: 36171158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.